annual CFO:
-$128.41M+$16.67M(+11.49%)Summary
- As of today (May 31, 2025), AXSM annual cash flow from operations is -$128.41 million, with the most recent change of +$16.67 million (+11.49%) on December 31, 2024.
- During the last 3 years, AXSM annual CFO has fallen by -$20.18 million (-18.65%).
- AXSM annual CFO is now -7772.60% below its all-time high of -$1.63 million, reached on December 31, 2013.
Performance
AXSM Cash from operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFO:
-$43.38M-$17.17M(-65.54%)Summary
- As of today (May 31, 2025), AXSM quarterly cash flow from operations is -$43.38 million, with the most recent change of -$17.17 million (-65.54%) on March 31, 2025.
- Over the past year, AXSM quarterly CFO has increased by +$10.09 million (+18.88%).
- AXSM quarterly CFO is now -3642.77% below its all-time high of -$1.16 million, reached on March 31, 2015.
Performance
AXSM quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
-$118.32M+$10.09M(+7.86%)Summary
- As of today (May 31, 2025), AXSM TTM cash flow from operations is -$118.32 million, with the most recent change of +$10.09 million (+7.86%) on March 31, 2025.
- Over the past year, AXSM TTM CFO has increased by +$74.41 million (+38.61%).
- AXSM TTM CFO is now -10109.51% below its all-time high of -$1.16 million, reached on March 31, 2015.
Performance
AXSM TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
AXSM Cash from operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +11.5% | +18.9% | +38.6% |
| 3 y3 years | -18.6% | -32.8% | -4.1% |
| 5 y5 years | -176.9% | -86.4% | -96.7% |
AXSM Cash from operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -18.6% | +11.5% | -645.1% | +21.6% | -31.9% | +38.6% |
| 5 y | 5-year | -176.9% | +11.5% | -645.1% | +21.6% | -96.7% | +38.6% |
| alltime | all time | -7772.6% | +11.5% | -3642.8% | +21.6% | <-9999.0% | +38.6% |
AXSM Cash from operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$43.38M(+65.5%) | -$118.32M(-7.9%) |
| Dec 2024 | -$128.41M(-11.5%) | -$26.20M(+40.6%) | -$128.41M(-3.1%) |
| Sep 2024 | - | -$18.63M(-38.1%) | -$132.57M(-20.8%) |
| Jun 2024 | - | -$30.11M(-43.7%) | -$167.49M(-13.1%) |
| Mar 2024 | - | -$53.47M(+76.1%) | -$192.73M(+32.8%) |
| Dec 2023 | -$145.08M(+24.5%) | -$30.36M(-43.3%) | -$145.08M(+2.0%) |
| Sep 2023 | - | -$53.55M(-3.3%) | -$142.28M(+27.6%) |
| Jun 2023 | - | -$55.35M(+850.9%) | -$111.49M(+24.3%) |
| Mar 2023 | - | -$5.82M(-78.9%) | -$89.68M(-23.0%) |
| Dec 2022 | -$116.51M(+7.7%) | -$27.56M(+21.1%) | -$116.51M(-1.1%) |
| Sep 2022 | - | -$22.76M(-32.1%) | -$117.79M(-3.3%) |
| Jun 2022 | - | -$33.54M(+2.7%) | -$121.81M(+7.2%) |
| Mar 2022 | - | -$32.65M(+13.2%) | -$113.66M(+5.0%) |
| Dec 2021 | -$108.23M(+37.9%) | -$28.84M(+7.7%) | -$108.23M(+8.3%) |
| Sep 2021 | - | -$26.78M(+5.4%) | -$99.94M(+12.4%) |
| Jun 2021 | - | -$25.39M(-6.7%) | -$88.90M(+7.9%) |
| Mar 2021 | - | -$27.22M(+32.4%) | -$82.40M(+5.0%) |
| Dec 2020 | -$78.46M(+69.2%) | -$20.55M(+30.6%) | -$78.46M(+4.0%) |
| Sep 2020 | - | -$15.73M(-16.7%) | -$75.47M(+7.3%) |
| Jun 2020 | - | -$18.90M(-18.8%) | -$70.36M(+17.0%) |
| Mar 2020 | - | -$23.27M(+32.5%) | -$60.15M(+29.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | -$46.38M(+54.3%) | -$17.57M(+65.3%) | -$46.38M(+20.1%) |
| Sep 2019 | - | -$10.63M(+22.4%) | -$38.60M(+13.9%) |
| Jun 2019 | - | -$8.68M(-8.6%) | -$33.89M(+3.1%) |
| Mar 2019 | - | -$9.50M(-3.0%) | -$32.87M(+9.4%) |
| Dec 2018 | -$30.05M(+13.5%) | -$9.79M(+65.7%) | -$30.05M(+13.2%) |
| Sep 2018 | - | -$5.91M(-22.9%) | -$26.55M(-2.0%) |
| Jun 2018 | - | -$7.67M(+14.8%) | -$27.09M(+2.2%) |
| Mar 2018 | - | -$6.68M(+6.2%) | -$26.52M(+0.2%) |
| Dec 2017 | -$26.47M(+24.4%) | -$6.29M(-2.4%) | -$26.47M(-3.4%) |
| Sep 2017 | - | -$6.45M(-9.1%) | -$27.40M(+6.4%) |
| Jun 2017 | - | -$7.10M(+6.9%) | -$25.75M(+7.4%) |
| Mar 2017 | - | -$6.64M(-8.0%) | -$23.97M(+12.6%) |
| Dec 2016 | -$21.28M(+186.1%) | -$7.22M(+50.3%) | -$21.28M(+30.4%) |
| Sep 2016 | - | -$4.80M(-9.6%) | -$16.32M(+21.4%) |
| Jun 2016 | - | -$5.31M(+34.6%) | -$13.44M(+31.4%) |
| Mar 2016 | - | -$3.95M(+75.4%) | -$10.23M(+37.5%) |
| Dec 2015 | -$7.44M(+61.8%) | -$2.25M(+17.1%) | -$7.44M(+43.4%) |
| Sep 2015 | - | -$1.92M(-8.7%) | -$5.19M(+58.9%) |
| Jun 2015 | - | -$2.11M(+81.8%) | -$3.27M(+181.8%) |
| Mar 2015 | - | -$1.16M | -$1.16M |
| Dec 2014 | -$4.60M(+181.8%) | - | - |
| Dec 2013 | -$1.63M | - | - |
FAQ
- What is Axsome Therapeutics annual cash flow from operations?
- What is the all time high annual CFO for Axsome Therapeutics?
- What is Axsome Therapeutics annual CFO year-on-year change?
- What is Axsome Therapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for Axsome Therapeutics?
- What is Axsome Therapeutics quarterly CFO year-on-year change?
- What is Axsome Therapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for Axsome Therapeutics?
- What is Axsome Therapeutics TTM CFO year-on-year change?
What is Axsome Therapeutics annual cash flow from operations?
The current annual CFO of AXSM is -$128.41M
What is the all time high annual CFO for Axsome Therapeutics?
Axsome Therapeutics all-time high annual cash flow from operations is -$1.63M
What is Axsome Therapeutics annual CFO year-on-year change?
Over the past year, AXSM annual cash flow from operations has changed by +$16.67M (+11.49%)
What is Axsome Therapeutics quarterly cash flow from operations?
The current quarterly CFO of AXSM is -$43.38M
What is the all time high quarterly CFO for Axsome Therapeutics?
Axsome Therapeutics all-time high quarterly cash flow from operations is -$1.16M
What is Axsome Therapeutics quarterly CFO year-on-year change?
Over the past year, AXSM quarterly cash flow from operations has changed by +$10.09M (+18.88%)
What is Axsome Therapeutics TTM cash flow from operations?
The current TTM CFO of AXSM is -$118.32M
What is the all time high TTM CFO for Axsome Therapeutics?
Axsome Therapeutics all-time high TTM cash flow from operations is -$1.16M
What is Axsome Therapeutics TTM CFO year-on-year change?
Over the past year, AXSM TTM cash flow from operations has changed by +$74.41M (+38.61%)